Ciprofloxacin Market: By Dosage Form, By Application, By Distribution Channel and Region Forecast 2020-2031

download arrow download arrow Download Sample
settings arrow settings arrow email us

Ciprofloxacin Market Size, Share, Growth, Trends, and Global Industry Analysis: By Dosage Form (Powder, Suspension, Tablet, Eye drops, Intravenous preparation), By Application (Urinary Tract Infections, Lower Respiratory Infections, Nosocomial Pneumonia, Skin Structure Infections, Bone and Joint Infections, Intra-Abdominal Infection, Acute Sinusitis, Chronic Bacterial Prostatitis), By Distribution Channel (Hospitals Pharmacies, Retail pharmacies, Drug stores, Online pharmacies) and Region Forecast 2020-2031

checked icon checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Ciprofloxacin Market Size was valued at US$ x million in 2023 and is poised to grow at a 7.2% CAGR from 2024 to 2030. Ciprofloxacin is one of the broad-spectrum antibiotics for the drug class quinolone antibiotic. To maintain the antibiotic's effectiveness, the antibiotic Ciprofloxacin is largely employed to stop the growth of bacteriophages that are resistant to it. Only bacterial illnesses are treated with the medication ciprofloxacin; viral infections are not affected by it. The Urinary Tract Infections segment anticipated to grow at significant CAGR over the forecast years owing to Due to differences in anatomy, women are more likely than men to get urinary tract infections. In their lifetimes, many women get urinary tract infections more than once.

According to some research, there are 150 million cases of urinary tract infections worldwide. Additionally, about 11% of women see a doctor for treatment of a UTI once a year. Moreover, competitors are focusing on launching and acquisition to maintain growth in the market. For instance, In December 2002 FDA Approves Once-Daily Cipro XR for the Treatment of Uncomplicated Urinary Tract Infections (UTIs). Increase in prevalence of bacterial infection such as (UTI), eye infections, among others is anticipated to create lucrative growth opportunities for the ciprofloxacin market.

summary download arrow Download Sample

Ciprofloxacin Market Summary

Study Period

2025-2031

Base Year

2024

CAGR

7.2%

Largest Market

North-America

Fastest Growing Market

Asia-Pacific

Ciprofloxacin Market Dynamics

The incidence of kidney infections and eye infections is one of the main factors propelling the Ciprofloxacin market's expansion. due to higher efficacy of Ciprofloxacin in treating the infections associated with the excretory system especially renal and urinary system. In June 2018 the US FDA warned the manufacturers and issued guidelines for the labeling black box warning mentioning safety warnings for the fluoroquinolones category of medicines. Considering the drug's negative effects on tendons and skin in paediatric and geriatric patients. It is projected that there would be a significant increase in demand for ciprofloxacin because of the requirement for broad spectrum antibiotics in the global pharmaceutical market.

Ciprofloxacin Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2025-2031

Market CAGR

7.2%

By Dosage Form

  • Powder
  • Suspension
  • Tablet
  • Eye drops
  • Intravenous preparation

By Application

  • Urinary Tract Infections
  • Lower Respiratory Infections
  • Nosocomial Pneumonia
  • Skin Structure Infections
  • Bone and Joint Infections
  • Intra-Abdominal Infection
  • Acute Sinusitis
  • Chronic Bacterial Prostatitis

By Distribution Channel

  • Hospitals Pharmacies
  • Retail pharmacies
  • Drug stores
  • Online pharmacies

By Region

  • North America (USA, Canada)
  • Europe (Germany, UK, France, Spain, Italy , Rest of Europe)
  • The Asia Pacific (China, India, Japan, Australia, South Korea, Rest of Asia- Pacific)
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America)
  • MEA (Saudi Arabia, UAE, South Africa, Rest of MEA)

Key Features of the Report

  • The ciprofloxacin market report provides granular level information about the market size, regional market share, historic market (2020-2024), and forecast (2025-2031)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about Market entry strategies, regulatory framework, and reimbursement scenarios.
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis 

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The ciprofloxacin market Size was valued at US$ x million in 2023 and is poised to grow at a 7.2% CAGR from 2024 to 2030.

The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

The market key players are Novartis International AG, Allergan plc, Merck & Co Inc, Cipla Limited, Bayer AG, Cadila Healthcare, Glenmark Pharmaceuticals, Hexal, Sanofi Synthelabo, Pfleger, Mylan Laboratories Ltd

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Ciprofloxacin Market Introduction 
2.1.Global Ciprofloxacin Market  - Taxonomy
2.2.Global Ciprofloxacin Market  - Definitions
2.2.1.Dosage Form
2.2.2.Application 
2.2.3.Distribution Channel
2.2.4.Region
3.Global Ciprofloxacin Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Ciprofloxacin Market Analysis, 2020 - 2024 and Forecast 2025 - 2031
4.1.  Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Ciprofloxacin Market  By Dosage Form, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
5.1. Powder
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Suspension
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Tablet
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Eye drops
5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Intravenous preparation
5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6.Global Ciprofloxacin Market  By Application , 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
6.1. Urinary Tract Infections
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Lower Respiratory Infections
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Nosocomial Pneumonia
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Skin Structure Infections
6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Bone and Joint Infections
6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Intra-Abdominal Infection
6.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Acute Sinusitis
6.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
6.8. Chronic Bacterial Prostatitis
6.8.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.8.3. Market Opportunity Analysis 
7.Global Ciprofloxacin Market  By Distribution Channel, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
7.1. Hospitals Pharmacies
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail pharmacies
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Drug stores
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Online pharmacies
7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Ciprofloxacin Market  By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Ciprofloxacin Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
9.1. Dosage Form Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Powder
9.1.2.Suspension
9.1.3.Tablet
9.1.4.Eye drops
9.1.5.Intravenous preparation
9.2.  Application  Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Urinary Tract Infections
9.2.2.Lower Respiratory Infections
9.2.3.Nosocomial Pneumonia
9.2.4.Skin Structure Infections
9.2.5.Bone and Joint Infections
9.2.6.Intra-Abdominal Infection
9.2.7.Acute Sinusitis
9.2.8.Chronic Bacterial Prostatitis
9.3.  Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals Pharmacies
9.3.2.Retail pharmacies
9.3.3.Drug stores
9.3.4.Online pharmacies
9.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Ciprofloxacin Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
10.1. Dosage Form Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Powder
10.1.2.Suspension
10.1.3.Tablet
10.1.4.Eye drops
10.1.5.Intravenous preparation
10.2.  Application  Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Urinary Tract Infections
10.2.2.Lower Respiratory Infections
10.2.3.Nosocomial Pneumonia
10.2.4.Skin Structure Infections
10.2.5.Bone and Joint Infections
10.2.6.Intra-Abdominal Infection
10.2.7.Acute Sinusitis
10.2.8.Chronic Bacterial Prostatitis
10.3.  Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals Pharmacies
10.3.2.Retail pharmacies
10.3.3.Drug stores
10.3.4.Online pharmacies
10.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11.Asia Pacific (APAC) Ciprofloxacin Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
11.1. Dosage Form Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Powder
11.1.2.Suspension
11.1.3.Tablet
11.1.4.Eye drops
11.1.5.Intravenous preparation
11.2.  Application  Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Urinary Tract Infections
11.2.2.Lower Respiratory Infections
11.2.3.Nosocomial Pneumonia
11.2.4.Skin Structure Infections
11.2.5.Bone and Joint Infections
11.2.6.Intra-Abdominal Infection
11.2.7.Acute Sinusitis
11.2.8.Chronic Bacterial Prostatitis
11.3.  Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals Pharmacies
11.3.2.Retail pharmacies
11.3.3.Drug stores
11.3.4.Online pharmacies
11.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Ciprofloxacin Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
12.1. Dosage Form Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Powder
12.1.2.Suspension
12.1.3.Tablet
12.1.4.Eye drops
12.1.5.Intravenous preparation
12.2.  Application  Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Urinary Tract Infections
12.2.2.Lower Respiratory Infections
12.2.3.Nosocomial Pneumonia
12.2.4.Skin Structure Infections
12.2.5.Bone and Joint Infections
12.2.6.Intra-Abdominal Infection
12.2.7.Acute Sinusitis
12.2.8.Chronic Bacterial Prostatitis
12.3.  Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals Pharmacies
12.3.2.Retail pharmacies
12.3.3.Drug stores
12.3.4.Online pharmacies
12.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Ciprofloxacin Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
13.1. Dosage Form Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Powder
13.1.2.Suspension
13.1.3.Tablet
13.1.4.Eye drops
13.1.5.Intravenous preparation
13.2.  Application  Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Urinary Tract Infections
13.2.2.Lower Respiratory Infections
13.2.3.Nosocomial Pneumonia
13.2.4.Skin Structure Infections
13.2.5.Bone and Joint Infections
13.2.6.Intra-Abdominal Infection
13.2.7.Acute Sinusitis
13.2.8.Chronic Bacterial Prostatitis
13.3.  Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals Pharmacies
13.3.2.Retail pharmacies
13.3.3.Drug stores
13.3.4.Online pharmacies
13.4.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Novartis International AG
14.2.2.Allergan plc
14.2.3.Merck & Co Inc
14.2.4.Cipla Limited
14.2.5.Bayer AG
14.2.6.Cadila Healthcare
14.2.7.Glenmark Pharmaceuticals
14.2.8.Hexal
14.2.9.Sanofi Synthelabo
14.2.10.Pfleger
14.2.11.Mylan Laboratories Ltd
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Novartis International AG
  • Allergan plc
  • Merck & Co Inc
  • Cipla Limited
  • Bayer AG
  • Cadila Healthcare
  • Glenmark Pharmaceuticals
  • Hexal
  • Sanofi Synthelabo
  • Pfleger
  • Mylan Laboratories Ltd

Related Industry Reports

Healthcare Hospital Food Services Market

Perfusion Systems Market

Upadacitinib API Market

Opicapone API Market